SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-16-110884
Filing Date
2016-06-30
Accepted
2016-06-30 17:11:39
Documents
1
Period of Report
2016-06-29

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT v443329_4.html 4  
1 OWNERSHIP DOCUMENT v443329_4.xml 4 3950
  Complete submission text file 0001144204-16-110884.txt   5523
Mailing Address 24 WEST 40TH STREET 8TH FLOOR NEW YORK NY 10018
Business Address 24 WEST 40TH STREET 8TH FLOOR NEW YORK NY 10018 (646) 350-0702
Akari Therapeutics Plc (Issuer) CIK: 0001541157 (see all company filings)

IRS No.: 981034922 | State of Incorp.: X0
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CELSUS THERAPEUTICS PLC 24 WEST 40TH STREET NEW YORK NY 10018
Business Address
Cohen Mark S (Reporting) CIK: 0001622779 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36288 | Film No.: 161743871